Invention Grant
- Patent Title: Coagulation factor VII polypeptides
-
Application No.: US12762867Application Date: 2010-04-19
-
Publication No.: US08133975B2Publication Date: 2012-03-13
- Inventor: Henrik Østergaard
- Applicant: Henrik Østergaard
- Applicant Address: CH Zurich
- Assignee: Novo Nordisk Health Care A/G
- Current Assignee: Novo Nordisk Health Care A/G
- Current Assignee Address: CH Zurich
- Agent Michael J. Brignati
- Priority: DK200301296 20030909
- Main IPC: C07K1/00
- IPC: C07K1/00

Abstract:
The present invention relates to novel coagulation Factor VII polypeptides, polynucleotide constructs encoding such polypeptides, as well as vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
Public/Granted literature
- US08674074B2 Coagulation factor VII polypeptides Public/Granted day:2014-03-18
Information query